Dr. Charles Stringfellow Cobbs, MD

Dr. Cobbs practices at Swedish Cherry Hill Campus in Seattle, Washington, part of Providence Health & Services.

Dr. Cobbs' NPI, 1497793467, was assigned on June 3, 2006. Dr. Cobbs graduated from Heersink School of Medicine - Birmingham in 1991. Dr. Cobbs holds Washington license MD60341679.

Dr. Cobbs' primary practice is Swedish Cherry Hill Campus, at 500 17th Avenue, Seattle, WA 98122 in King County. The practice phone is (206) 320-2000.

Dr. Cobbs' primary practice is Swedish Cherry Hill Campus in Seattle, Washington, part of Providence Health & Services. Dr. Cobbs is also affiliated with Swedish Issaquah Campus. The medical group on file is Swedish Health Services. Dmand AI also links Dr. Cobbs to 2 more hospitals, 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cobbs practices, 6 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Cobbs' primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Cobbs is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Cobbs' licenses on file in 6 states: Washington, California, Alaska, Montana, Florida and Alabama.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, lower back pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Cobbs treats.

CMS data shows 272 Medicare services from Dr. Cobbs across 8 procedure codes in 2024, for 153 Medicare patients. Medicare paid $70,104 for them.

CMS counts 153 Medicare patients who saw Dr. Cobbs in 2024. The largest group is 65 to 74, with 85 patients. 69% of them have high cholesterol, and 65% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cobbs' median patient age at 69, with 61% women.

In 2024, Dr. Cobbs wrote 20 Medicare Part D claims for 17 patients. 100% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $244 in total drug cost. In 2018, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Cobbs for performance year 2024, reported as part of a group. Dr. Cobbs accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cobbs as offering telehealth. CMS counts 28 procedures of laminectomy or laminotomy (partial removal of spine bones) by Dr. Cobbs, more than 59% of the clinicians it reports for that procedure.

Dmand AI links 97 papers to Dr. Cobbs, published from 2007 to 2024. 2018 was the busiest year, with 9. The most frequent topics are Brain Neoplasms, Glioblastoma and Cytomegalovirus. Dr. Cobbs has published most often in J Neurooncol. Dr. Cobbs' most frequent co-authors are Ryder P. Gwinn, MD, Andrew Lin Ko, MD and Jeffrey G. Ojemann.

Dmand AI links Dr. Cobbs to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Brain Neoplasms.

CMS Open Payments shows 13 general payments to Dr. Cobbs from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Integra LifeSciences Corporation paid the most, $525.

Dmand AI lists 2 awards for Dr. Cobbs.

Dr. Cobbs graduated from Heersink School of Medicine - Birmingham in 1991. Dr. Cobbs is a member of CNS.

Dr. Cobbs is in network with 19 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.